Allogeneic umbilical cord-derived cd34- cells, non-expanded, Dorocubicel
Zemcelpro
Indication
Treatment of adult patients with haematological malignancies requiring an allogeneic haematopoietic stem cell transplantation following myeloablative conditioning for whom no other type of suitable donor cells is available
In other countries
The same active substances on other registers, the same brand first.
National listings
The national registers that list this EU medicine.
Documents
The official texts, at the regulator.